IMMUNIC IMUX 深 沪
等待开盘 08-17 09:30:00 美东时间
16.06
-0.520
-3.14%
华盛通- 最 高16.8399
- 今 开16.60
- 成交量 7.97万股
- 最 低 15.86
- 昨 收 16.58
- 总市值 2.19亿
- 52周最高 16.8624
- 市盈率 静 --
- 换手率 0.58%
- 52周最低 5.062
- 委 比 -33.33%
- 总股本 1362.15万
- 历史最高 289.90
- 量 比 0.43
- 振 幅 5.91%
- 历史最低 5.062
- 每 手 1
- 风险率 3.02%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Immunic Q2 EPS $(0.80) Beats $(1.10) Estimate
Immunic (NASDAQ:IMUX) reported quarterly losses of $(0.80) per share which beat the analyst consensus estimate of $(1.10) by 27.27 percent. This is a 60 percent increase over losses of $(2.00) per share from the same period last year.
08-11 18:36
Immunic Appoints Elena Ridloff to Board of Directors
– Appointment Strengthens Board with Financial, Capital Markets and Commercial Leadership Expertise as the Company Approaches Pivotal Phase 3 ENSURE Readout in Relapsing Multiple Sclerosis a...
08-11 04:05
Immunic Names CEO Erik Lundgren to Board
Immunic ( ($IMUX) ) has issued an announcement. On June 29, 2026, Immunic direc...
07-07 04:45
EXCLUSIVE: Immunic Appoints Former Genentech Exec Erik Lundgren As CEO
Immunic (IMUX) stock rises premarket to $13.14 as the company names former Genentech executive Erik Lundgren as CEO. See how his historic multiple sclerosis drug launch experience accelerates Immunic's Phase 3 trials in 2026.
05-27 18:17
B. Riley Securities Maintains Buy on Immunic, Lowers Price Target to $27
B. Riley Securities analyst William Woods maintains Immunic (NASDAQ:IMUX) with a Buy and lowers the price target from $40 to $27.
05-22 22:16
Immunic Appoints Michael W. Bonney As Board Chairman
Mr. Bonney brings more than three decades of leadership experience in the biopharmaceutical industry, including significant expertise in multiple sclerosis (MS) and broader central nervous system markets. Notably, during
05-19 18:32
Earnings Scheduled For May 13, 2026
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to re...
05-13 19:11
